Jackson Square Capital LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 8,451 shares of the biopharmaceutical company’s stock, valued at approximately $1,037,000. A number of other large investors have also made changes to their positions in GILD. Brighton […]